Role of Paraoxonase in Diabetic Vascular Complications by Oxidative Stress

对氧磷酶在氧化应激引起的糖尿病血管并发症中的作用

基本信息

  • 批准号:
    11671125
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Human serum paraoxonase (PON1) inhibits the oxidation of low-density lipoprotein, suggesting that PON1 protects against atherosclerosis. Oxidative stress in diabetic condition is involved in developments of diabetic macro- and microangiopathy. We studied whether PON1 was involved in the development of diabetic vascular injury through the oxidative stress.Every enzyme activity of PON1, paraoxonase, arylesterase or diazoxonase, was decreased in patients with type 2 diabetes as compared with normal controls, which suggested that PON1 functions in diabetic patients were disturbed. We established an ELISA for PON1 concentrations and found that the level of PON1 in diabetic patients was not different from that in normal controls, which suggested that PON1 might be up-regulated in diabetes.We investigated the promoter region of PON1 gene and found a novel polymorphism -108C/T, which influenced the transcription activity of PON1 and the serum concentrations. Further investigation of promoter region using reporter gene assay showed the PON1 transcription activity was suppressed by IL-1 and promoted by IL-6. Stimulation of oxidized LDL suppressed the PON1 transcription activity in early phase, but promoted in late phase. We also proved that Sp1 transcription factor played an important role in the PON1 transcription.The results suggested that the ability of PON1 which inhibited against oxidation were disturbed in diabetic patients, which was involved in the diabetic angiopathy, and oxidative stress in diabetes affects the PON1 transcription.
人血清对氧磷酶(PON 1)抑制低密度脂蛋白的氧化,表明PON 1对动脉粥样硬化具有保护作用。糖尿病状态下的氧化应激参与了糖尿病大血管和微血管病变的发展。我们研究了PON 1是否通过氧化应激参与了糖尿病血管损伤的发生发展,发现2型糖尿病患者PON 1的对氧磷酶、芳基酯酶和二氮氧磷酶的活性均较正常对照组降低,提示糖尿病患者PON 1的功能受到了干扰。我们建立了检测糖尿病患者血清中PON 1水平的ELISA方法,发现糖尿病患者血清中PON 1水平与正常对照组无明显差异,提示糖尿病患者PON 1水平可能上调,我们对PON 1基因启动子区进行了研究,发现了一个新的多态性-108C/T,该多态性影响PON 1的转录活性和血药浓度。通过报告基因分析进一步研究了PON 1的启动子区,发现IL-1抑制PON 1的转录活性,而IL-6促进PON 1的转录活性。氧化型LDL刺激后,PON 1的转录活性在早期受到抑制,而在晚期受到促进。结果表明,糖尿病患者PON 1抗氧化能力受到干扰,参与糖尿病血管病变的发生,糖尿病时氧化应激影响PON 1的转录。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
末廣正,他: "Paraoxonaseと遺伝子多型."動脈硬化. 27. 105-110 (2000)
Tadashi Suehiro 等人:“对氧磷酶和遗传多态性”。27. 105-110 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Suehiro T, et al.: "A polymorhism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression."Atherosclerosis. 150. 295-298 (2000)
Suehiro T 等人:“人类对氧磷酶 (PON1) 基因上游的多态性及其与 PON1 表达的关联。”动脉粥样硬化。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUEHIRO Tadashi其他文献

SUEHIRO Tadashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUEHIRO Tadashi', 18)}}的其他基金

Detection for Mutant of Apolipoprotein E Gene by GC-clamp Denaturing Gradient Gel Electrophoresis
GC夹变性梯度凝胶电泳检测载脂蛋白E基因突变
  • 批准号:
    03671155
  • 财政年份:
    1991
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Spin Distribution and Chemical Reactivity of sigma-Free Radicals
西格玛自由基的自旋分布和化学反应性
  • 批准号:
    02640404
  • 财政年份:
    1990
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Cell-free hemoglobin-oxidized LDL-LOX-1 axis and microvascular hyperpermeability during sepsis
脓毒症期间无细胞血红蛋白氧化的 LDL-LOX-1 轴和微血管通透性过高
  • 批准号:
    10739620
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Oxidized LDL dependent reprogramming of the liver lymphatic endothelium
氧化LDL依赖性肝淋巴内皮重编程
  • 批准号:
    10596498
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Oxidized LDL dependent reprogramming of the liver lymphatic endothelium
氧化LDL依赖性肝淋巴内皮重编程
  • 批准号:
    10371256
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Oxidized LDL dependent reprogramming of the liver lymphatic endothelium
氧化LDL依赖性肝淋巴内皮重编程
  • 批准号:
    10176480
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Oxidized LDL dependent reprogramming of the liver lymphatic endothelium
氧化LDL依赖性肝淋巴内皮重编程
  • 批准号:
    10028083
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Analysis and application of carbohydrate binding specificity of oxidized LDL receptor
氧化型LDL受体碳水化合物结合特异性分析及应用
  • 批准号:
    19K05886
  • 财政年份:
    2019
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of syncytiotrophoblast extracellular vesicles on angiotensin II-induced vasoconstriction in uterine arteries from lectin-like oxidized LDL receptor-1 overexpressing mice
合体滋养层细胞外囊泡对血管紧张素 II 诱导的凝集素样氧化 LDL 受体 1 过表达小鼠子宫动脉血管收缩的影响
  • 批准号:
    400208
  • 财政年份:
    2019
  • 资助金额:
    $ 2.3万
  • 项目类别:
Quantitative method of oxidized LDL in blood using high-functional peptides and its application to in vitro diagnosis
高效能肽定量测定血液中氧化LDL及其在体外诊断中的应用
  • 批准号:
    16K19201
  • 财政年份:
    2016
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The origin of the oxidized LDL in arterial wall in the cause of cerebral vasospasm
动脉壁氧化LDL导致脑血管痉挛的根源
  • 批准号:
    15K19947
  • 财政年份:
    2015
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Studies on process of generation and metabolism of oxidized LDL in vivo.
体内氧化型低密度脂蛋白生成及代谢过程的研究。
  • 批准号:
    15K07944
  • 财政年份:
    2015
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了